Advertisement

Topics

"Global Regional Electronic Grade Phosphoric Acid Market Research" Drugs and Medication Database

05:46 EST 19th February 2019 | BioPortfolio

Here are the most relevant "Global Regional Electronic Grade Phosphoric Acid Market Research" Drugs and Medications that we have found in our database.

More Information about "Global Regional Electronic Grade Phosphoric Acid Market Research" on BioPortfolio

We have published hundreds of Global Regional Electronic Grade Phosphoric Acid Market Research news stories on BioPortfolio along with dozens of Global Regional Electronic Grade Phosphoric Acid Market Research Clinical Trials and PubMed Articles about Global Regional Electronic Grade Phosphoric Acid Market Research for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Global Regional Electronic Grade Phosphoric Acid Market Research Companies in our database. You can also find out about relevant Global Regional Electronic Grade Phosphoric Acid Market Research Drugs and Medications on this site too.

Showing "Global Regional Electronic Grade Phosphoric Acid Market Research" Drugs and Medications 1–25 of 538

Probably Relevant

Ionite apf [dharma research, inc.]

NA

Ionite apf [dharma research, inc.]

NA

Ionite apf [dharma research, inc.]

NA

Ionite apf [dharma research, inc.]

NA

Ionite apf [dharma research, inc.]

NA

Ionite apf [dharma research, inc.]

NA

Ionite apf [dharma research, inc.]

NA

Ionite apf [dharma research, inc.]

NA

Ionite apf [dharma research, inc.]

NA

Ionite apf [dharma research, inc.]

NA

Ionite apf [dharma research, inc.]

NA

Ionite apf [dharma research, inc.]

NA

Ionite apf [dharma research, inc.]

NA

Doxil [janssen products, lp]

These highlights do not include all the information needed to use DOXIL safely and effectively. See full prescribing information for DOXIL. DOXIL (doxorubicin hydrochloride liposome injection), for intravenous useInitial U.S. Approval: 1995

Doxorubicin hydrochloride liposome [janssen products, lp]

These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for Doxorubicin hydrochloride (HCl) liposome injection. Doxorubicin HCl Liposome Inject

Doxorubicin hydrochloride [northstar rxllc]

These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION . DOXORUBICIN HYDROCHLORIDE liposome i

Doxorubicin hydrochloride [sun pharmaceutical industries, inc.]

These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION.  DOXORUBICIN HYDROCHLORIDE LIPOSOME

Temozolomide [amerigen pharmaceuticals inc.]

These highlights do not include all the information needed to use TEMOZOLOMIDE safely and effectively. See full prescribing information for TEMOZOLOMIDE. TEMOZOLOMIDE (TEMOZOLOMIDE) CAPSULE for ORAL use. Initial U.S. Approval: 1999

Doxorubicin hydrochloride [bluepoint laboratories]

These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDELIPOSOME INJECTION safely and effectively. See full prescribing information for doxorubicin hydrochloride liposome injection.DOXORUBICIN HYDROCHLORIDELIPOSOME INJEC

Fludeoxyglucose f18 [the methodist hospital research institute]

Fludeoxyglucose F18 Injection USP - NO CHANGE

Gelato neutral ph [deepak products, inc.]

NA

Trichloroacetic acid 15% [crc (cosmoceutical research center)]

NA

Trichloroacetic acid 50% [crc (cosmoceutical research center)]

NA

Trichloroacetic acid 30% [crc (cosmoceutical research center)]

NA

Possibly Relevant

Ibrance [pfizer laboratories div pfizer inc]

These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE (palbociclib) capsules, for oral use Initial U.S. Approval: 2015



Advertisement
Quick Search
Advertisement
Advertisement